In the training cohort, patients with proliferative HCC were younger (P = 0.02) and had higher serum AFP levels (P = 0.003) but lower albumin levels (P = 0.01) compared with patients with nonproliferative HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.